Should women be offered cholesterol lowering drugs to prevent cardiovascular disease?

被引：19

作者：

Grundy, Scott M.

机构：

[1] Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA

来源：

BRITISH MEDICAL JOURNAL | 2007年 / 334卷 / 7601期

关键词：

D O I：

10.1136/bmj.39202.399942.AD

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Women in western countries are more likely to die from heart disease than from cancer. Scott M Grundy argues that the risks make preventive treatment essential, but Malcolm Kendrick believes the evidence of benefit is not strong enough. © 2007, BMJ Publishing Group Ltd. All rights reserved.

引用

页码：982 / 983

页数：2

共 16 条

[1]

Final report, Circulation, 106, pp. 3143-3421, (2002)

[2]

Grundy S.M., Cleeman J.I., Merz C.N., Brewer H.B., Clark L.T., Hunninghake D.B., Et al., Implications of recent clinical trials for the National Cholesterol Education Program adult treatment panel III guidelines, Circulation, 110, pp. 227-239, (2004)

[3]

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S), Lancet, 344, pp. 1383-1389, (1994)

[4]

Sacks F.M., Tonkin A.M., Shepherd J., Braunwald E., Cobbe S., Hawkins C.M., Et al., Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the prospective pravastatin pooling project, Circulation, 102, pp. 1893-1900, (2000)

[5]

MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, pp. 7-22, (2002)

[6]

LaRosa J.C., He J., Vupputuri S., Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials, JAMA, 199, 282, pp. 2340-2346

[7]

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins, Lancet, 366, pp. 1267-1278, (2005)

[8]

Abramson J., Wright J.M., Are lipid-lowering guidelines evidence based?, Lancet, 369, pp. 168-169, (2007)

[9]

Lloyd-Jones D.M., Wilson P.W., Larson M.G., Leip E., Beiser A., D'Agostino R.B., Et al., Lifetime risk of coronary heart disease by cholesterol levels at selected ages, Arch Intern Med, 163, pp. 1966-1972, (2003)

[10]

McGill H.C., McMahan C.A., Malcom G.T., Oalmann M.C., Strong J.P., Effects of serum lipoproteins and smoking on atherosclerosis in young men and women, Arterioscler Thromb Vasc Biol, 17, pp. 95-106, (1997)

← 1 2 →